II. Indications
- Blood Pressure Management in Pregnancy
- 
                          Refractory Hypertension
                          - Effective outpatient agent in oral form patients with Refractory Hypertension
 
- 
                          Hypertensive Emergency
                          - Labetalol is a preferred agent when compared with Hydaralazine and Clonidine
- 
                              Nicardipine and Clevidipine have replaced intravenous Labetalol for Hypertensive Emergency- Labetalol is difficult to achieve Blood Pressure control in Hypertensive Crisis despite titration
- Labetalol is short acting
 
 
III. Contraindications
IV. Pharmacokinetics
- Not lipophilic
- Hepatic metabolism
- 
                          Bioavailability 20 to 40%- Well absorbed but high first-pass hepatic metabolism
- Bioavailability increased when taken with food
 
V. Mechanism
- Not Cardioselective
- Primary activity is as a negative inotrope- Chronotropic effect is mild
 
- Combination of classes (similar to Carvedilol)- Lowers Blood Pressure without reflex Tachycardia
- Nonselective Beta Blocker (7 fold more beta than alpha activity)- Binds vascular (and Bronchial) Smooth Muscle beta receptors
- Decreases Heart Rate, Cardiac Output and Blood Pressure
 
- Selective Alpha-1 Adrenergic Antagonist (weak compared with beta activity)- Competitively binds vascular Smooth Muscle alpha-1 Adrenergic Receptors
- Blocks peripheral blood vessel Vasoconstriction
 
 
VI. Dosing: Adults
- Adjust dose in liver and renal Impairment
- Oral
- Intravenous Injection- Start: 20 mg slow IV injection
- Next: 40-80 mg every 10 minutes as needed
- Cummulative Maximum: 200-300 mg
 
- Intravenous Infusion- Start 0.5 to 2 mg/min IV up to cummulative maximum of 200-300 mg
 
VII. Dosing: Children (Not FDA approved)
- Oral- Start: 4 mg/kg/day orally divided twice daily
- Maximum: 40 mg/kg/day up to adult maximum of 2400 mg
 
- Intravenous Infusion- Dose: 0.3 to 1 mg/kg/dose up to 20 mg slow IV injection up to every 10 minutes
- Cummulative Maximum: 200-300 mg
 
- Intravenous Infusion- Start 0.4 to 1 mg/kg/hour IV up to 3 mg/kg/hour
 
VIII. Adverse Effects
- May worsen acute exacerbations of Congestive Heart Failure
- Fatigue
- Erectile Dysfunction
- Orthostatic Hypotension
IX. Drug Interactions
- Systemic Beta Agonists- Labetalol blocks bronchodilation
 
X. Safety
- Pregnancy Category C
- Safe in Lactation
XI. Resources
- Labetalol Injection (DailyMed)
- Labetalol Tablet (DailyMed)
XII. References
- (2019) Presc Lett, Resource #350503, Comparison of Oral Beta Blockers
- Olson (2020) Clinical Pharmacology, MedMaster, Miami, p. 66
- Hamilton (2020) Tarascon Pocket Pharmacopeia, Jones and Bartlett, accessed on IOS, 4/9/2021
Images: Related links to external sites (from Bing)
Related Studies
| labetalol (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| LABETALOL HCL 100 MG TABLET | Generic | $0.12 each | 
| LABETALOL HCL 200 MG TABLET | Generic | $0.16 each | 
| LABETALOL HCL 300 MG TABLET | Generic | $0.21 each | 
